Related Experiment Videos
Copper protects against galactosamine-induced hepatitis
L Barrow1, A Kantarjian, M S Tanner
1Department of Child Health, University of Leicester, U.K.
Journal of Hepatology
|August 1, 1987
Summary
Copper supplementation protected rats against D-galactosamine-induced hepatitis, suggesting a potential therapeutic role for copper in liver disease. This study investigates copper
Area of Science:
- Hepatology
- Toxicology
- Gastroenterology
Background:
- Copper is implicated in hepatotoxicity in Wilson's disease and Indian Childhood Cirrhosis (ICC).
- Rats exhibit minimal hepatic damage despite copper loading.
- Investigating copper's role in potentiating superimposed hepatitis.
Purpose of the Study:
- To determine if copper deposition exacerbates or protects against D-galactosamine (GalN)-induced hepatitis in rats.
- To explore the mechanisms behind copper's effect on liver injury.
Main Methods:
- Copper loading in rats via oral supplementation.
- Administration of D-galactosamine (GalN) to induce hepatitis.
- Measurement of serum liver enzymes (AST, ALT, OCT) and histological examination of liver tissue.
- Analysis of viable bacterial counts in fecal homogenates.
Main Results:
- GalN induced significant liver damage and elevated liver enzymes in control rats.
- Copper-loaded rats showed markedly reduced GalN-induced liver enzyme elevations and minimal histological damage.
- Copper supplementation reduced viable anaerobic bacteria in rat feces.
Conclusions:
- Copper loading appears to protect against GalN-induced hepatitis in rats.
- Potential mechanisms include reduced gut-derived endotoxin, impaired prostaglandin synthesis, or altered acute-phase reactant synthesis.
- Findings challenge the assumption of universal copper hepatotoxicity and suggest a protective role in specific contexts.